CINF vs COLL · P/E 16, rev $11.34B vs P/E 17, rev $181.9M
Cincinnati Financial Corporation (CINF) versus Collegium Pharmaceutical Inc (COLL) — a side-by-side from cached financials, not a winner call.
Cincinnati Financial Corporation (CINF) is a insurance - property & casualty company listed on US.
Collegium Pharmaceutical Inc (COLL) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Latest reported CINF revenue for 2024-12-31 was $11.34B. Net income was $2.29B. Revenue was up 13.2% from 2023-12-31 to 2024-12-31. CINF currently screens at market cap $22.83B and trailing P/E 15.9.
Latest reported COLL revenue for 2024-12-31 was $181.9M. Net income was $69.2M. Revenue was up 14.2% from 2024-09-30 to 2024-12-31. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
CINF currently screens at market cap $22.83B and trailing P/E 15.9. COLL currently screens at market cap $1.12B and trailing P/E 16.8.
Not investment advice. Open the CINF and COLL stock pages for the full models.
Not investment advice.